Healthcare DIVE March 21, 2025
Rebecca Pifer

The massive PBM is pivoting to a cost-based reimbursement model, which it says will reduce variation in how pharmacies are paid. Pharmacy groups say that depends on the specifics of Optum Rx’s plan.

Dive Brief:

  • Optum Rx is shifting to a new pharmacy reimbursement model that should result in pharmacies being paid more for brand-name drugs and less for generics. It’s the latest move from a major drug middleman to reform how pharmacies are paid amid widespread criticism of the status quo.
  • Optum Rx said Thursday that it would pay pharmacies in a cost-based model, which should give them more reliable revenue and allow them to stock more drugs, also helping consumers access their medications.
  • The massive pharmacy benefit...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech
Which Biopharma Startups Made the Cut for INVEST Pitch Perfect?
Eli Lilly Adds Alzheimer’s Care to Digital Health Platform Services
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
Building for the Healthcare Consumer with Elliot Cohen
Fortune: The 61 most innovative companies in healthcare

Share This Article